AAOMS Annual Meeting

The US Food and Drug Administration has approved a new option for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

The US Food and Drug Administration has approved a new option for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

The US Food and Drug Administration has approved a new option for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

Lorazepam Oral Concentrate has been voluntarily recalled by Amneal Pharmaceuticals.

Lorazepam Oral Concentrate has been voluntarily recalled by Amneal Pharmaceuticals.

Lorazepam Oral Concentrate has been voluntarily recalled by Amneal Pharmaceuticals.

The FDA has announced a recall of pravastatin tablets due to mislabeling.

The FDA has announced a recall of pravastatin tablets due to mislabeling.

The FDA has announced a recall of pravastatin tablets due to mislabeling.

In response to several reported deaths, the FDA has issued a warning to alert health care providers of potential mortality risk related to intragastric balloon systems.